Authors:
Takatsuki, K
Kawahara, S
Takehara, K
Kishimoto, Y
Kirino, Y
Citation: K. Takatsuki et al., Effects of the noncompetitive NMDA receptor antagonist MK-801 on classicaleyeblink conditioning in mice, NEUROPHARM, 41(5), 2001, pp. 618-628
Authors:
Yamada, Y
Tomonaga, M
Fukuda, H
Hanada, S
Utsunomiya, A
Tara, M
Sano, M
Ikeda, S
Takatsuki, K
Kozuru, M
Araki, K
Kawano, F
Niimi, M
Tobinai, K
Hotta, T
Shimoyama, M
Citation: Y. Yamada et al., A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303, BR J HAEM, 113(2), 2001, pp. 375-382
Authors:
Yagita, M
Huang, CL
Umehara, H
Matsuo, Y
Tabata, R
Miyake, M
Konaka, Y
Takatsuki, K
Citation: M. Yagita et al., A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, LEUKEMIA, 14(5), 2000, pp. 922-930
Authors:
Asou, N
Suzushima, H
Nishimura, S
Okubo, T
Yamasaki, H
Osato, M
Hoshino, K
Takatsuki, K
Mitsuya, H
Citation: N. Asou et al., Long-term remission in an elderly patient with mantle cell leukemia treated with low-dose cyclophosphamide, AM J HEMAT, 63(1), 2000, pp. 35-37
Authors:
Sonoki, T
Matsuzaki, H
Nagasaki, A
Hata, H
Yoshida, M
Matsuoka, M
Kuribayashi, N
Kimura, T
Harada, N
Takatsuki, K
Mitsuya, H
Mori, M
Citation: T. Sonoki et al., Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis byNOS inhibitor, LEUKEMIA, 13(5), 1999, pp. 713-718
Authors:
Etoh, K
Yamaguchi, K
Tokudome, S
Watanabe, T
Okayama, A
Stuver, S
Mueller, N
Takatsuki, K
Matsuoka, M
Citation: K. Etoh et al., Rapid quantification of HTLV-I provirus load: Detection of monoclonal proliferation of HTLV-I-infected cells among blood donors, INT J CANC, 81(6), 1999, pp. 859-864
Authors:
Fujii, S
Fujimoto, K
Shimizu, K
Ezaki, T
Kawano, F
Takatsuki, K
Kawakita, M
Matsuno, K
Citation: S. Fujii et al., Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34(+) hematopoietic progenitor cells: Induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients, CANCER RES, 59(9), 1999, pp. 2150-2158
Authors:
Osato, M
Asou, N
Abdalla, E
Hoshino, K
Yamasaki, H
Okubo, T
Suzushima, H
Takatsuki, K
Kanno, T
Shigesada, K
Ito, Y
Citation: M. Osato et al., Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2 alpha B gene associated with myeloblastic leukemias, BLOOD, 93(6), 1999, pp. 1817-1824
Authors:
Kuribayashi, N
Hata, H
Matsuzaki, H
Yoshida, M
Sonoki, T
Nagasaki, A
Kimura, T
Harada, N
Takatsuki, K
Citation: N. Kuribayashi et al., Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration, MED ONCOL, 15(4), 1998, pp. 248-254